Skip to main content
. 2017 Jul 31;8(47):82643–82660. doi: 10.18632/oncotarget.19740

Table 3. Results of clinicopathological factors related to EMMPRIN overexpression.

Subgroup No. of studies Cases Pooled OR 95% CI P value
Tumor stage (T3+T4/T1+T2) 24 4769 1.87 1.64-2.12 <0.0001
Differentiation (poor/ well +moderate) 14 3476 1.09 1.60-2.23 <0.0001
Clinical stage (III+IV/I+II) 25 4734 1.96 1.69-2.27 <0.0001
Nodal metastasis (negative/ positive) 12 2010 2.37 1.93-2.90 <0.0001